JP2023521631A5 - - Google Patents
Info
- Publication number
- JP2023521631A5 JP2023521631A5 JP2022559959A JP2022559959A JP2023521631A5 JP 2023521631 A5 JP2023521631 A5 JP 2023521631A5 JP 2022559959 A JP2022559959 A JP 2022559959A JP 2022559959 A JP2022559959 A JP 2022559959A JP 2023521631 A5 JP2023521631 A5 JP 2023521631A5
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- formula
- compound
- crystal
- diffraction angles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2005114.0A GB202005114D0 (en) | 2020-04-07 | 2020-04-07 | Crystalline Forms of a Pharmaceutical Compound |
| GB2005114.0 | 2020-04-07 | ||
| PCT/EP2021/058864 WO2021204762A1 (en) | 2020-04-07 | 2021-04-06 | Crystalline forms of a tyk2 inhibitor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521631A JP2023521631A (ja) | 2023-05-25 |
| JP2023521631A5 true JP2023521631A5 (https=) | 2024-04-01 |
| JP7660135B2 JP7660135B2 (ja) | 2025-04-10 |
Family
ID=70768933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559959A Active JP7660135B2 (ja) | 2020-04-07 | 2021-04-06 | Ｔｙｋ２阻害剤の結晶形態 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12545652B2 (https=) |
| EP (1) | EP4132649A1 (https=) |
| JP (1) | JP7660135B2 (https=) |
| KR (1) | KR20220164751A (https=) |
| CN (1) | CN115515683B (https=) |
| AU (1) | AU2021253128A1 (https=) |
| BR (1) | BR112022016359A2 (https=) |
| CA (1) | CA3167172A1 (https=) |
| GB (1) | GB202005114D0 (https=) |
| IL (1) | IL296989A (https=) |
| MX (1) | MX2022011593A (https=) |
| WO (1) | WO2021204762A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
| WO2023183910A1 (en) * | 2022-03-25 | 2023-09-28 | Nimbus Lakshmi, Inc. | Solid forms of tyk2 inhibitors and methods of use |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794096A (fr) | 1972-08-07 | 1973-05-16 | Lepetit Spa | Oxazoles 2,4,5-trisubstitues et leur preparation |
| GB1497536A (en) | 1973-12-17 | 1978-01-12 | Lilly Industries Ltd | 2-acylaminooxazoles methods for their preparation and their use |
| JPH0753716B2 (ja) | 1986-07-02 | 1995-06-07 | 吉富製薬株式会社 | イミダゾ−ルカルボキサミド誘導体 |
| DE19653355A1 (de) | 1996-12-20 | 1998-06-25 | Dresden Arzneimittel | Neue, antikonvulsiv wirkende Aminoimidazole und Verfahren zu ihrer Herstellung |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| IL153246A0 (en) | 2000-06-28 | 2003-07-06 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
| DE60128731T2 (de) | 2000-10-30 | 2008-02-07 | Janssen Pharmaceutica N.V. | Tripeptidylpeptidase-hemmer |
| US7361665B2 (en) | 2002-07-09 | 2008-04-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| EP1684750B1 (en) | 2003-10-23 | 2010-04-28 | AB Science | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| GB0504753D0 (en) | 2005-03-08 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
| JP5222561B2 (ja) | 2005-10-07 | 2013-06-26 | キッセイ薬品工業株式会社 | 含窒素芳香族複素環化合物およびそれを含有する医薬組成物 |
| ES2352320T3 (es) | 2006-05-12 | 2011-02-17 | Ab Science | Nuevo procedimiento para la síntesis de compuestos de 2-aminoxazol. |
| WO2008024980A2 (en) | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| GB0709031D0 (en) | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| JP5478488B2 (ja) | 2007-06-20 | 2014-04-23 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｊａｎｕｓキナーゼの阻害剤 |
| EP2278969B1 (en) | 2008-04-21 | 2013-02-13 | Merck Sharp & Dohme Corp. | Inhibitors of Janus kinases |
| EP2299816B1 (en) | 2008-06-18 | 2013-11-13 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases |
| US8420695B2 (en) | 2008-07-09 | 2013-04-16 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases |
| EP2166006A1 (en) | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| GB0820819D0 (en) | 2008-11-13 | 2008-12-24 | Sareum Ltd | Pharmaceutical compounds |
| US20130096104A1 (en) | 2010-03-17 | 2013-04-18 | Genentech, Inc. | Imidazopyridine compounds, compositions and methods of use |
| EP2588105A1 (en) | 2010-07-01 | 2013-05-08 | Cellzome Limited | Triazolopyridines as tyk2 inhibitors |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| CN103987713A (zh) | 2011-10-12 | 2014-08-13 | 阵列生物制药公司 | 5,7-取代的咪唑并[1,2-c]嘧啶 |
| EP3040336B1 (en) | 2012-03-02 | 2020-04-08 | Sareum Limited | Compounds for use in treating tyk2 kinase mediated conditions |
| KR101202026B1 (ko) | 2012-07-03 | 2012-11-16 | 민호현 | 황토 석부작 제조 방법 |
| LT3495358T (lt) | 2012-11-08 | 2022-05-25 | Bristol-Myers Squibb Company | Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai |
| MX369974B (es) * | 2013-09-03 | 2019-11-27 | Sareum Ltd | Compuestos farmaceuticos. |
| NO2721710T3 (https=) | 2014-08-21 | 2018-03-31 | ||
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
| GB201816369D0 (en) * | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
-
2020
- 2020-04-07 GB GBGB2005114.0A patent/GB202005114D0/en not_active Ceased
-
2021
- 2021-04-06 CA CA3167172A patent/CA3167172A1/en active Pending
- 2021-04-06 CN CN202180025999.3A patent/CN115515683B/zh active Active
- 2021-04-06 KR KR1020227038120A patent/KR20220164751A/ko active Pending
- 2021-04-06 EP EP21717041.4A patent/EP4132649A1/en active Pending
- 2021-04-06 IL IL296989A patent/IL296989A/en unknown
- 2021-04-06 MX MX2022011593A patent/MX2022011593A/es unknown
- 2021-04-06 JP JP2022559959A patent/JP7660135B2/ja active Active
- 2021-04-06 AU AU2021253128A patent/AU2021253128A1/en active Pending
- 2021-04-06 WO PCT/EP2021/058864 patent/WO2021204762A1/en not_active Ceased
- 2021-04-06 BR BR112022016359A patent/BR112022016359A2/pt unknown
- 2021-04-06 US US17/905,183 patent/US12545652B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101391132B1 (ko) | 결정형 미노사이클린 염기 및 이의 제조방법 | |
| JP2022176979A5 (https=) | ||
| JP2019104760A (ja) | ベンズイミダゾール誘導体の新規結晶形及びその製造方法 | |
| JP2018528199A5 (https=) | ||
| JP2023521631A5 (https=) | ||
| KR102266680B1 (ko) | 벨리노스테트의 다형태 및 이의 제조 방법 | |
| WO2006053781A1 (en) | Process of making crystalline aripiprazole | |
| WO2018210302A1 (zh) | 一种苯并呋喃类衍生物游离碱的晶型及制备方法 | |
| JP2024521412A5 (https=) | ||
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| CN115572298B (zh) | 一种核苷类似物及其盐的晶型、制备方法和应用 | |
| CA2806820A1 (en) | N-methylformamide solvate of dasatinib | |
| CN107531744A (zh) | 一种奥贝胆酸的新结晶形式及其制备方法 | |
| TWI666207B (zh) | 一種苯并哌啶類衍生物的鹽、其晶型及鹽、其晶型的製備方法 | |
| TW202033508A (zh) | 貝前列素-314d晶體及其製備方法 | |
| WO2014195977A2 (en) | Novel polymorphs of vismodegib | |
| CN101925602B (zh) | 基本上不含溶剂的阿巴卡韦的结晶形式 | |
| JP2025031139A (ja) | ジヒドロスフィンゴミエリンの結晶、及び、その製造方法、並びに、医薬組成物 | |
| JP4655930B2 (ja) | キノリンカルボン酸誘導体溶媒和物の結晶 | |
| RU2022120823A (ru) | Кристаллические формы ингибитора tyk2 | |
| CN116096369A (zh) | 布鲁顿酪氨酸激酶抑制剂的多晶型物及其制备方法和应用 | |
| JP6944372B2 (ja) | ピペラジン化合物の新規結晶 | |
| JP6577938B2 (ja) | セフジトレンピボキシルの新規結晶形態およびその製造方法 | |
| KR20150127996A (ko) | 실로도신 감마형 결정의 제조방법 | |
| KR102727487B1 (ko) | 트레프로스티닐 디에탄올아민염의 다형체 형태 b의 제조 방법 |